top of page

Press Releases and News 

Pluristyx and panCELLa Expand Intellectual Property Portfolio for Pluripotent Stem Cell Cloaking Technology

Pluristyx and panCELLa Expand Intellectual Property Portfolio for Pluripotent Stem Cell Cloaking Technology

January 12, 2023

Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement

Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement

October 6, 2022

Pluristyx and Blood Cell Storage, Inc. Announces Partnership

Pluristyx and Blood Cell Storage, Inc. Announces Partnership

August 2, 2022

Pluristyx and Accelerated Biosciences announce availability of clinical-grade immune-privileged human trophoblast stem cells (hTSCs)

Pluristyx and Accelerated Biosciences announce availability of clinical-grade immune-privileged human trophoblast stem cells (hTSCs)

April 27, 2022

Pluristyx announces strategic alliance with panCELLa and Implant Therapeutics of offer 'off-the-shelf' induced pluripotent stem cells.

Pluristyx announces strategic alliance with panCELLa and Implant Therapeutics of offer 'off-the-shelf' induced pluripotent stem cells.

January 20, 2022

bottom of page